These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9626043)

  • 1. Dysregulated expression of CD66a (BGP, C-CAM), an adhesion molecule of the CEA family, in endometrial cancer.
    Bamberger AM; Riethdorf L; Nollau P; Naumann M; Erdmann I; Götze J; Brümmer J; Schulte HM; Wagener C; Löning T
    Am J Pathol; 1998 Jun; 152(6):1401-6. PubMed ID: 9626043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression pattern of osteopontin in endometrial carcinoma: correlation with expression of the adhesion molecule CEACAM1.
    Briese J; Schulte HM; Bamberger CM; Löning T; Bamberger AM
    Int J Gynecol Pathol; 2006 Apr; 25(2):161-9. PubMed ID: 16633066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD66a (human C-CAM) and other members of the carcinoembryonic antigen gene family of adhesion molecules in human colorectal adenomas.
    Nollau P; Scheller H; Kona-Horstmann M; Rohde S; Hagenmüller F; Wagener C; Neumaier M
    Cancer Res; 1997 Jun; 57(12):2354-7. PubMed ID: 9192807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of biliary glycoprotein (CD66a) in normal and malignant breast epithelial cells.
    Huang J; Simpson JF; Glackin C; Riethorf L; Wagener C; Shively JE
    Anticancer Res; 1998; 18(5A):3203-12. PubMed ID: 9858884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adhesion molecule CEACAM1 (CD66a, C-CAM, BGP) is specifically expressed by the extravillous intermediate trophoblast.
    Bamberger AM; Sudahl S; Löning T; Wagener C; Bamberger CM; Drakakis P; Coutifaris C; Makrigiannakis A
    Am J Pathol; 2000 Apr; 156(4):1165-70. PubMed ID: 10751340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer.
    Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ; Lu CH; Chiou LC
    Clin Cancer Res; 2003 Apr; 9(4):1393-8. PubMed ID: 12684410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of pp60c-src with biliary glycoprotein (CD66a), an adhesion molecule of the carcinoembryonic antigen family downregulated in colorectal carcinomas.
    Brümmer J; Neumaier M; Göpfert C; Wagener C
    Oncogene; 1995 Oct; 11(8):1649-55. PubMed ID: 7478590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-26 is expressed in human endometrium but not in endometrial carcinoma.
    Isaka K; Nishi H; Nakai H; Nakada T; Feng Li Y; Ebihara Y; Takayama M
    Cancer; 2003 Jan; 97(1):79-89. PubMed ID: 12491508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of carcinoembryonic antigen group members CGM2, CD66a (biliary glycoprotein), and nonspecific cross-reacting antigen in colorectal carcinomas. Comparative analysis by northern blot and in situ hybridization.
    Nollau P; Prall F; Helmchen U; Wagener C; Neumaier M
    Am J Pathol; 1997 Aug; 151(2):521-30. PubMed ID: 9250164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers.
    Xiong Y; Dowdy SC; Xue A; Shujuan J; Eberhardt NL; Podratz KC; Jiang SW
    Gynecol Oncol; 2005 Mar; 96(3):601-9. PubMed ID: 15721400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of carcinoembryonic antigen family member 2 expression is an early event in colorectal tumorigenesis.
    Thompson J; Seitz M; Chastre E; Ditter M; Aldrian C; Gespach C; Zimmermann W
    Cancer Res; 1997 May; 57(9):1776-84. PubMed ID: 9135022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of E-cadherin and beta-catenin in the normal and malignant human endometrium: an inverse correlation between E-cadherin and nuclear beta-catenin expression.
    Shih HC; Shiozawa T; Miyamoto T; Kashima H; Feng YZ; Kurai M; Konishi I
    Anticancer Res; 2004; 24(6):3843-50. PubMed ID: 15736420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential mRNA expression of urokinase-type plasminogen activator, plasminogen activator receptor and plasminogen activator inhibitor type-2 in normal human endometria and endometrial carcinomas.
    Foca C; Moses EK; Quinn MA; Rice GE
    Gynecol Oncol; 2000 Nov; 79(2):244-50. PubMed ID: 11063652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-suppressive activity of CD66a in prostate cancer.
    Luo W; Tapolsky M; Earley K; Wood CG; Wilson DR; Logothetis CJ; Lin SH
    Cancer Gene Ther; 1999; 6(4):313-21. PubMed ID: 10419049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
    Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
    Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclical change of hMSH2 protein expression in normal endometrium during the menstrual cycle and its overexpression in endometrial hyperplasia and sporadic endometrial carcinoma.
    Hamid AA; Mandai M; Konishi I; Nanbu K; Tsuruta Y; Kusakari T; Kariya M; Kita M; Fujii S
    Cancer; 2002 Feb; 94(4):997-1005. PubMed ID: 11920468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of maspin in endometrioid adenocarcinoma of endometrium.
    Li HW; Leung SW; Chan CS; Yu MM; Wong YF
    Oncol Rep; 2007 Feb; 17(2):393-8. PubMed ID: 17203179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of CD66a (BGP), a cell adhesion molecule of the carcinoembryonic antigen family, in benign, premalignant, and malignant lesions of the human mammary gland.
    Riethdorf L; Lisboa BW; Henkel U; Naumann M; Wagener C; Löning T
    J Histochem Cytochem; 1997 Jul; 45(7):957-63. PubMed ID: 9212821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of fos and jun proto-oncogenes in benign versus malignant human uterine tissue.
    Nephew KP; Choi CM; Polek TC; McBride R; Bigsby RM; Khan SA; Husseinzadeh N
    Gynecol Oncol; 2000 Mar; 76(3):388-96. PubMed ID: 10684716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.